OpenLB
Open Library of Bioscience
Advanced Search
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Oct 15, 2010;51 (8): 985-6; author reply 987-9.

Safety, censoring, and intent-to-treat analysis: dangers to generalizability.

David R Boulware
Author Information
PMID: 20858076 DOI: 10.1086/656436

Abstract

No abstract text available.

References

  1. Clin Infect Dis. 1998 Feb;26(2):284-9 [PMID: 9502443]
  2. J Antimicrob Chemother. 2010 Feb;65(2):316-9 [PMID: 20032007]
  3. BMC Infect Dis. 2007 Mar 12;7:14 [PMID: 17352798]
  4. Clin Infect Dis. 2010 Jun 1;50(11):1532-8 [PMID: 20415574]
  5. Clin Infect Dis. 1998 Jun;26(6):1362-6 [PMID: 9636863]

Grants

  1. K23 AI073192/NIAID NIH HHS
  2. L30 AI066779/NIAID NIH HHS
  3. K23AI073192-01A2/NIAID NIH HHS

MeSH Term

Acquired Immunodeficiency Syndrome
Africa South of the Sahara
Alanine Transaminase
Anti-HIV Agents
Antifungal Agents
Antiretroviral Therapy, Highly Active
Fluconazole
Humans
Liver
Liver Function Tests
Meningitis, Cryptococcal
Nevirapine

Chemicals

Anti-HIV Agents
Antifungal Agents
Fluconazole
Nevirapine
Alanine Transaminase
Comment Letter Research Support, N.I.H., Extramural

Word Cloud

Created with Highcharts 10.0.0Safetycensoringintent-to-treatanalysis:dangersgeneralizability

Similar Articles

Cited By